Yaron Carmi

13PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 27, 2024
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.

Avishai Maliah, Nadine Santana-Magal, Shivang Parikh

|Jun 17, 2024
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity.

Leen Farhat-Younis, Manho Na, Amichai Zarfin

|Apr 02, 2024
Author Correction: Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.

Breanna M Allen, Kamir J Hiam, Cassandra E Burnett

|Apr 18, 2023
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.

Diana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig

Pageof 3